Atomoxetine for Attention-Deficit/Hyperactivity Disorder Symptoms in Children with Pervasive Developmental Disorders: APilot Study

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of child and adolescent psychopharmacology

• Publication date

  2006-10-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1089/cap.2006.16.611PMID 17069549
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Medication treatment in subjects with autistic spectrum disorders

  2009cited by this paper
• Non-stimulant treatments for ADHD

  2009cited by this paper
• Autism Diagnostic Interview—Revised

  2008cited by this paper
• ADHD Rating Scale-IV: Checklists, Norms, and Clinical Interpretation

  2006influential reference
• Retrospective Assessment of Atomoxetine in Children and Adolescents with Pervasive Developmental Disorders

  2005influential reference
• Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.

  2005cited by this paper
• Long-term effects of risperidone in children with autism spectrum disorders: a placebo discontinuation study.

  2005cited by this paper
• Management of hyperactivity and other acting-out problems in patients with autism spectrum disorder.

  2004cited by this paper
• [Autism and pervasive developmental disorders].

  2004cited by this paper
• Autism and pervasive developmental disorders.

  2004cited by this paper
• Relapse prevention in pediatric patients with ADHD treated with atomoxetine: a randomized, double-blind, placebo-controlled study.

  2004cited by this paper
• A prospective, multicenter, open-label assessment of atomoxetine in non-North American children and adolescents with ADHD

  2004cited by this paper
• Guanfacine Treatment of Hyperactivity and Inattention in Pervasive Developmental Disorders: A Retrospective Analysis of 80 Cases

  2004cited by this paper
• Risperidone in children with autism and serious behavioral problems.

  2002cited by this paper
• Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial.

  2002cited by this paper
• A double-blind comparison of desipramine and placebo in children and adolescents with chronic tic disorder and comorbid attention-deficit/hyperactivity disorder.

  2002cited by this paper
• Difference in serotonergic and noradrenergic regulation of human social behaviours

  2001cited by this paper
• A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder.

  2001cited by this paper
• Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study.

  2001cited by this paper
• A Controlled Study of Nortriptyline in Children and Adolescents with Attention Deficit Hyperactivity Disorder

  2000cited by this paper
• Efficacy of Methylphenidate Among Children with Autism and Symptoms of Attention-Deficit Hyperactivity Disorder

  2000cited by this paper
• Depressive Disorders in Childhood and Adolescence: A Clinical Perspective

  1999cited by this paper
• Adults with attention-deficit/hyperactivity disorder: a controversial diagnosis.

  1998cited by this paper
• Adhd Rating Scale-IV: Checklists, Norms, and Clinical Interpretation

  1998influential reference
• Conners' rating scales-revised : technical manual

  1997influential reference
• Bupropion hydrochloride in attention deficit disorder with hyperactivity.

  1996cited by this paper
• Medication treatment strategies in the MTA Study: relevance to clinicians and researchers.

  1996cited by this paper
• Catecholamines in attention-deficit hyperactivity disorder: current perspectives.

  1996cited by this paper
• Stimulant drugs in the developmental disabilities revisited

  1996cited by this paper
• Psychotropic and anticonvulsant drugs in subjects with autism: prevalence and patterns of use.

  1995cited by this paper
• Autism Diagnostic Interview-Revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders

  1994cited by this paper
• [Affective disorders in the fourth edition of the classification of mental disorders prepared by the American Psychiatric Association -- diagnostic and statistical manual of mental disorders].

  1993cited by this paper
• Fenfluramine and methylphenidate in children with mental retardation and attention deficit hyperactivity disorder: Laboratory effects

  1993cited by this paper
• Clonidine Treatment of Hyperactive and Impulsive Children with Autistic Disorder

  1992cited by this paper
• The effects of haloperidol on discrimination learning and behavioral symptoms in autistic children

  1989cited by this paper
• A double-blind placebo controlled study of desipramine in the treatment of ADD: I. Efficacy.

  1989cited by this paper
• The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects.

  1985cited by this paper
• Wechsler intelligence scale for children

  1949cited by this paper

• Children and Adolescents with Co-Occurring Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder: A Systematic Review of Multimodal Interventions

  2025influential citation
• Exploring the Relationship of Dietary Intake With Inattention, Hyperactivity, and Impulsivity, Beyond ADHD

  2024cites this paper
• Off-label psychopharmacological interventions for autism spectrum disorders: strategic pathways for clinicians

  2023influential citation
• Pharmacological intervention for irritability, aggression, and self-injury in autism spectrum disorder (ASD).

  2023cites this paper
• The pediatric psychopharmacology of autism spectrum disorder: A systematic review - Part I: The past and the present.

  2021cites this paper
• Efficacy and Safety of Medication for Attention-Deficit Hyperactivity Disorder in Children and Adolescents with Common Comorbidities: A Systematic Review

  2021cites this paper
• Autism Spectrum Disorder

  2021cites this paper
• www.ssoar.info Shared heritability of attention-deficit/ hyperactivity disorder and autism spectrum disorder

  2021cites this paper
• Treatment in autism spectrum disorder

  2020cites this paper
• Atomoxetine for attention deficit hyperactivity disorder in children and adolescents with autism: A systematic review and meta‐analysis

  2019cites this paper
• Improvement of ADHD symptoms in School Age Children and Adolescents with Autism via a Digital Smartglasses-based Socio-emotional Coaching Aid

  2018cites this paper
• Effects of Atomoxetine on Height and Weight in Korean Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Retrospective Chart Review

  2018cites this paper
• Protocol for the STAR (Sheffield Treatments for ADHD) project: an internal pilot study assessing the feasibility of the Trials within Cohorts (TwiCs) design to test the effectiveness of interventions for children with ADHD

  2018cites this paper
• A randomized, placebo-controlled trial of extended-release guanfacine in children with autism spectrum disorder and ADHD symptoms: an analysis of secondary outcome measures

  2018cites this paper
• Improvement of Attention-Deficit/Hyperactivity Disorder Symptoms in School-Aged Children, Adolescents, and Young Adults With Autism via a Digital Smartglasses-Based Socioemotional Coaching Aid: Short-Term, Uncontrolled Pilot Study

  2017cites this paper
• A review of the efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in children and adult patients with common comorbidities

  2017cites this paper
• Inattention and hyperactivity in association with autism spectrum disorders in the CHARGE study.

  2017cites this paper
• Neurocognitive and MRI correlates of Attention-Deficit/Hyperactivity symptoms in Autism Spectrum Disorder (ASD)

  2017cites this paper
• Psychopharmacological interventions in autism spectrum disorder

  2016cites this paper
• Functional consequences of attention‐deficit hyperactivity disorder on children and their families

  2016cites this paper
• Effects of Atomoxetine in Individuals with Attention-Deficit/Hyperactivity Disorder and Low-Functioning Autism Spectrum Disorder

  2016cites this paper
• Psychopharmacologic intervention for adults with autism spectrum disorder: A systematic literature review

  2016cites this paper
• Zur Therapie von ADHS bei komorbiden Autismus-Spektrum-Störungen

  2016cites this paper
• Update on psychopharmacology for autism spectrum disorders

  2016cites this paper
• Concerns Expressed by Parents of Children with Pervasive Developmental Disorders for Different Time Periods of the Day: A Case–Control Study

  2015cites this paper
• The Safety of Atomoxetine for the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Comprehensive Review of Over a Decade of Research

  2015cites this paper
• No Evidence for Predictors of Response to Atomoxetine Treatment of Attention-Deficit/Hyperactivity Disorder Symptoms in Children and Adolescents with Autism Spectrum Disorder

  2015cites this paper
• Autism Spectrum Disorder

  2015cites this paper
• Psychotropic Treatment of Autism

  2015cites this paper
• The Efficacy of Atomoxetine for the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Comprehensive Review of Over a Decade of Clinical Research

  2015cites this paper
• Maternal Mild Thyroid Hormone Insufficiency in Early Pregnancy and Attention-Deficit/Hyperactivity Disorder Symptoms in Children.

  2015cites this paper
• Attention-Deficit/Hyperactivity Disorder in Adults with High-Functioning Pervasive Developmental Disorders in Japan

  2014cites this paper
• What’s in the pipeline? Drugs in development for autism spectrum disorder

  2014cites this paper
• Psychopharmacological Interventions in Autism Spectrum Disorder

  2014cites this paper
• [Pharmacological treatments in patients with pervasive developmental disorders: A review].

  2014cites this paper
• A review of atomoxetine effects in young people with developmental disabilities.

  2014influential citation
• Psychopharmacological Interventions in Autism Spectrum Disorder

  2014cites this paper
• Atomoxetine in Autism Spectrum Disorder: No Effects on Social Functioning; Some Beneficial Effects on Stereotyped Behaviors, Inappropriate Speech, and Fear of Change

  2014cites this paper
• Behavioral and cognitive profiling in Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder

  2014cites this paper
• Efficacité des traitements pharmacologiques dans les troubles envahissants du développement : une revue de la littérature

  2014cites this paper
• Pharmacological Intervention for Disruptive Behaviors in Intellectual and Developmental Disabilities: The Glass is Half Full

  2013cites this paper
• Autismo y trastorno por déficit de atención/hiperactividad: intervención farmacológica

  2013cites this paper
• [Autism and attention deficit hyperactivity disorder: pharmacological intervention].

  2013cites this paper
• Atomoxetine for Treating ADHD Symptoms in Autism

  2013influential citation
• Efficacy of Atomoxetine for the Treatment of ADHD Symptoms in Patients With Pervasive Developmental Disorders

  2013influential citation
• The neurobehavioral and molecular phenotype of Angelman Syndrome

  2013cites this paper
• Counseling and Other Therapeutic Strategies for Children with AS and Their Families

  2013cites this paper
• A randomized double-blind study of atomoxetine versus placebo for attention-deficit/hyperactivity disorder symptoms in children with autism spectrum disorder.

  2012cites this paper
• Efficacy and Safety of Atomoxetine in the Treatment of Children and Adolescents with Attention Deficit Hyperactivity Disorder

  2012cites this paper
• Pharmacologic treatments for the behavioral symptoms associated with autism spectrum disorders across the lifespan

  2012cites this paper
• The Role of Co-Occurring Disruptive Behavior in the Clinical Presentation of Children and Adolescents with Anxiety in the Context of Autism Spectrum Disorders

  2012cites this paper
• Pharmacotherapy to control behavioral symptoms in children with autism

  2012cites this paper
• To stop or not to stop? How long should medication treatment of attention-deficit hyperactivity disorder be extended?

  2011influential citation
• Efficacy of Atomoxetine in Children With Severe Autistic Disorders and Symptoms of ADHD

  2011influential citation
• [Psychopharmacology of autism spectrum disorders].

  2011cites this paper
• ¿Suspender o no el tratamiento? ¿Durante cuánto tiempo debe mantenerse el tratamiento farmacológico del trastorno por déficit de atención/hiperactividad?

  2011cites this paper
• Lower IQ is Associated with Decreased Clinical Response to Atomoxetine in Children and Adolescents with Attention-Deficit Hyperactivity Disorder

  2011cites this paper
• Psychopharmakologie autistischer Störungen

  2011cites this paper
• Pharmacotherapy of Autism Spectrum Disorders

  2011cites this paper
• Response to atomoxetine in boys with high‐functioning autism spectrum disorders and attention deficit/hyperactivity disorder

  2011cites this paper
• Pharmacological Management in Children and Adolescents with Pervasive Developmental Disorder

  2010cites this paper
• Tetrahydrobiopterin as a novel therapeutic intervention for autism

  2010cites this paper
• Atomoxetine for attention deficit hyperactivity disorder in mental retardation.

  2010cites this paper
• Central Tetrahydrobiopterin Concentration in Neurodevelopmental Disorders

  2010cites this paper
• Shared heritability of attention-deficit/hyperactivity disorder and autism spectrum disorder

  2010cites this paper
• Diagnostik und Therapie von Autismus-Spektrum-Störungen im Kindesalter

  2010cites this paper
• Pharmacotherapy and children with autism spectrum disorder: a tutorial for speech-language pathologists.

  2010cites this paper
• Attention-deficit/Hyperactivity Disorder in the Context of Autism Spectrum Disorders

  2010cites this paper
• CAPÍTULO 14 – TDAH CON TRASTORNOS DEL ESPECTRO AUTISTA

  2010cites this paper
• Review of pharmacotherapy options for the treatment of attention-deficit/hyperactivity disorder (ADHD) and ADHD-like symptoms in children and adolescents with developmental disorders.

  2010cites this paper
• Atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents: a review

  2009cites this paper
• Use of Atomoxetine in Patients with Attention-Deficit Hyperactivity Disorder and Co-Morbid Conditions

  2009cites this paper
• Use of psychotropic medications in children with developmental disabilities.

  2008cites this paper
• Biological Treatment of Asperger'sDisorder

  2008cites this paper
• Autisme en psychofarmaca

  2008cites this paper
• Pharmacological Treatment Options for Autism Spectrum Disorders in Children and Adolescents

  2008cites this paper
• Treatment of inattention, overactivity, and impulsiveness in autism spectrum disorders.

  2008cites this paper
• Psychopharmacological treatment for very young children: contexts and guidelines.

  2007cites this paper
• [Psychopharmacology of autistic disorders].

  2007cites this paper
• When attention-deficit/hyperactivity disorder co-occurs with anxiety disorders: effects on treatment

  2007cites this paper
• Pharmacotherapy of Autism and Related Disorders

  2007cites this paper
• Drug Class Review on Pharmacologic Treatments for ADHD: Final Report

  2007cites this paper
• The status of pharmacotherapy for autism spectrum disorders

  2007cites this paper
• Pharmacologic treatment of autism and related disorders.

  2007cites this paper
• Drug Treatments for Pervasive Developmental Disorders: Expanding the Evidence Base

  2006cites this paper
• Drug Class Review on Pharmacologic Treatments for ADHD

  2005cites this paper